.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Daiichi Sankyo
US Department of Justice
Colorcon
Medtronic
Moodys
Deloitte
Novartis
Mallinckrodt
Cerilliant

Generated: December 18, 2017

DrugPatentWatch Database Preview

HYDROCORTONE Drug Profile

« Back to Dashboard

When do Hydrocortone patents expire, and when can generic versions of Hydrocortone launch?

Hydrocortone is a drug marketed by Merck and is included in four NDAs.

The generic ingredient in HYDROCORTONE is hydrocortisone. There are sixty drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the hydrocortisone profile page.

Summary for HYDROCORTONE

Drug patent expirations by year for HYDROCORTONE

Medical Subject Heading (MeSH) Categories for HYDROCORTONE

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
MerckHYDROCORTONEhydrocortisone acetateINJECTABLE;INJECTION008228-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
MerckHYDROCORTONEhydrocortisone acetateOINTMENT;OPHTHALMIC, OTIC009018-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
MerckHYDROCORTONEhydrocortisone acetateINJECTABLE;INJECTION008228-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
MerckHYDROCORTONEhydrocortisone sodium phosphateINJECTABLE;INJECTION012052-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
MerckHYDROCORTONEhydrocortisoneTABLET;ORAL008506-011Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
MerckHYDROCORTONEhydrocortisoneTABLET;ORAL008506-007Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cipla
AstraZeneca
McKinsey
Merck
McKesson
Medtronic
Dow
Accenture
Deloitte
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot